Paul Tudor Jones’s Immunovant IMVT Stock Holding History

Paul Tudor Jones’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.2M	Buy	+57,145	New	+$1.74M	﹤0.01%	1879
2026 Q1	–	Sell	-25,600	Closed	-$651K	–	3944
2025 Q4	$651K	Sell	25,600 -65,166	-72%	-$1.45M	﹤0.01%	2558
2025 Q3	$1.46M	Buy	+90,766	New	+$1.47M	﹤0.01%	2010
2024 Q2	–	Sell	-87,397	Closed	-$2.82M	–	2534
2024 Q1	$2.82M	Buy	87,397 +49,055	+128%	+$1.79M	0.02%	858
2023 Q4	$1.62M	Buy	+38,342	New	+$1.41M	0.01%	1211
2023 Q3	–	Sell	-14,333	Closed	-$272K	–	2553
2023 Q2	$272K	Sell	14,333 -52,686	-79%	-$983K	﹤0.01%	2059
2023 Q1	$1.04M	Buy	+67,019	New	+$1.16M	0.02%	1171

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Paul Tudor Jones's IMVT Position: Q2 2026 in Review

Paul Tudor Jones opened a new position in Immunovant (IMVT) in Q2 2026: 57,145 shares worth $2.2M. The stake represents ﹤0.01% of the portfolio and ranks #1879 among its holdings. This is a return to the name: Paul Tudor Jones previously reported a position in IMVT as recently as Q4 2025.

Paul Tudor Jones first reported a position in IMVT in Q1 2023 and has held it in 7 quarters since. The position peaked at $2.82M in Q1 2024. 224 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Paul Tudor Jones held 57,145 shares of Immunovant worth $2.2M as of Q2 2026.
Immunovant was a new Paul Tudor Jones position in Q2 2026.
Immunovant made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1879 holding.
Paul Tudor Jones first reported a position in Immunovant in Q1 2023 and has held it in 7 quarters since.
Paul Tudor Jones's Immunovant position peaked at $2.82M in Q1 2024.
224 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.